Molecular Mechanisms of Cancer

University Of Chicago, Chicago IL

Investigators

Linked publications & trials

Abstract

The overarching goal of the University of Chicago Medicine Comprehensive Cancer Center (UCCCC) Molecular Mechanisms of Cancer (MMC) Program is to catalyze collaborative efforts that leverage emerging scientific discoveries from the laboratories of MMC scientists and propel them in a translational direction that makes an impact on cancer prevention, diagnosis, and treatment for patients living in our catchment area and beyond. The University of Chicago is a hotbed of scientific innovation, and the MMC continues to maximize the health benefits that emerge from this science, informed by regional cancer burden trends. The MMC Program is centered on three key scientific and cancer-focused research themes: (1) deregulated gene expression and epigenetic defects in cancer; (2) altered cell growth and transformation; and (3) the tumor microenvironment in tumor growth and metastasis. These intersecting themes encompass the research of all members, across organ sites. The breadth and multi-disciplinary nature of our research contributes to the success of MMC in establishing productive translational collaborations both within MMC and across the other UCCCC programs. The MMC Program consists of 51 faculty members from 13 Departments, including 14 talented new faculty recruited to the institution in this funding cycle. In addition to increasing membership by 38% in this cycle, we increased the number and percentage of high-impact publications from 20% to 38% of total publications, increased NCI funding from $3.5M to $5M and launched 6 new working groups and multiple team science initiatives. Importantly, we have had increased success in moving our cutting-edge science into clinical trials, clinical applications, and/or commercialization. MMC leadership has fostered these successes by enhancing inter-programmatic collaborations, particularly with the UCCCC Clinical & Experimental Therapeutics Program via new working groups and targeted funding. Programmatic activities are informed by regional cancer burden trends and designed to reduce incidence and improve outcomes through the translation of laboratory-based insights into clinical strategies. Faculty engagement in scientific dissemination and public education has supported regional outreach goals. In the next cycle, the MMC will continue to support institutional efforts that strengthen research environments, attract high-caliber investigators, and provide structured mentoring and training to early-career cancer researchers.